Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis

Acta Dermato-Venereologica

Volumn 88, Issue 3, 2008, Pages 281-282

  Stinco, Giuseppe ^a   Piccirillo, Fabio ^a   Patrone, Pasquale ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; ETANERCEPT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHOTREXATE; RISPERIDONE; THROMBOCYTE ANTIBODY;

ADULT; BLOOD CELL COUNT; CASE REPORT; DISEASE SEVERITY; HUMAN; LABORATORY TEST; LETTER; LIVER DISEASE; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PSYCHOSIS; RELAPSE; REMISSION; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; THROMBOCYTOPENIA;

EID: 44349089899     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0400     Document Type: Letter

References (8)

1. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151: 1548-1561.
2. Keystone EC. Safety of biologic therapies - an update. J Rheumatol Suppl 2005; 74: 8-12.
3. Pathare SK, Heycock C, Hamilton J. TNFalpha blocker-induced thrombocytopenia. Rheumatology 2006; 45: 1313-1314.
4. Kuruvilla J, Leitch HA, Vickars LM, Galbraith PF, Li CH, Al-Saab S, Naiman SC. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor. Eur J Haematol 2003; 71: 396-398.
5. Hamaguchi M, Kawahito Y, Ishino H, Yoshida M, Yoshikawa T. A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis. Clin Rheumatol 2007; 26: 988-990.
6. Vidal F, Fontova R, Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 2003; 139: W-W63.
7. Salar A, Bessa X, Muniz E, Monfort D, Besses C, Andreu M. Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease. Gut 2007; 56: 1169-1170.
8. Jacobsen SE, Jacobsen FW, Fahlman C, Rusten LS. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells 1994; 12 Suppl 1: 111-126.